Home › Niet-kleincellige longkanker › Californië › Concord
Niet-kleincellige longkanker klinische studies in Concord, CA
14 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Concord (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mijl verwijderd
- John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mijl verwijderd
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mijl verwijderd
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
RekruterenFase 3
- Local Institution - 0208, Pleasant Hill · 3 mijl verwijderd
- BASS Cancer Center, Walnut Creek · 5 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruterenFase 3
- John Muir Health Clinical Research Center, Concord
- John Muir Health Cancer Center, Walnut Creek · 5 mijl verwijderd
- John Muir Health Clinical Research Center, Walnut Creek · 5 mijl verwijderd
- en nog 1
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- Kaiser Permanente Walnut Creek Medical Center, Walnut Creek · 5 mijl verwijderd
- John Muir Health Clinical Research Center, Walnut Creek · 5 mijl verwijderd
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruterenFase 3
- BASS Cancer Center, Walnut Creek · 5 mijl verwijderd
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RekruterenObservatieonderzoek
- John Muir Health, Walnut Creek · 5 mijl verwijderd
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekruterenFase 2/3
- John Muir Clinical Research Center, Concord
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 3
- Research Site, Walnut Creek · 5 mijl verwijderd
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruterenFase 3
- BASS Cancer Center, Walnut Creek · 5 mijl verwijderd
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekruterenFase 3
- Research Site, Walnut Creek · 5 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mijl verwijderd
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mijl verwijderd
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mijl verwijderd
- Contra Costa Regional Medical Center, Martinez · 6 mijl verwijderd
- Contra Costa Regional Medical Center, Martinez · 6 mijl verwijderd
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Concord
- Obesitas18 studies
- Overgewicht16 studies
- Ernstige depressieve stoornis12 studies
- Type 2-diabetes10 studies
- Borstkanker9 studies
- Longkanker9 studies
- Migraine8 studies
- Kanker (alle vormen)7 studies
- Depressie6 studies
- Prostaatkanker6 studies
- Diabetes5 studies
- Ziekte van Alzheimer5 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.